
By Adam Garcia
In Diabetic Lifestyle, we will be discussing a new public health notification.
This public health notification was issued from the FDA and according to them, you may get high blood glucose test results if you’re using test strips based on GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) andNOTE: This is not a recall, it is a warning.
The FDA has provided a list of test strips affected by this warning. These include: many Accu-chek products, Abbott FreeStyle strips, and TRUEtest strips. Several press releases have been issued from various manufacturers of blood glucose test strips concerning this circumstance. The one from Roche Diagnostics is the most useful. You can find it by clicking here. Table 2 lists some of the drugs that can cause maltose interference, about how many people are using them, and how they’re delivered. From this table it seems like Extraneal users is the group most likely to have people with diabetes. Bayer has posted a press release to say that their products are not affected by this warning. According to the Editor of the Diabetes Technology Blog, Bernard Farrell, Agamatrix and their strips are also not affected by this warning as they use glucose oxidase. If you’re affected by this warning and you encounter a false high reading, you can report issues directly to the FDA.
you’re taking medications that contains non-glucose sugars.